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Introduction
High altitude places are amongst the most inhospi-
table on earth. According to WHO [70] in 1966 there
were approximately 140 million people living at alti-
tudes over 2,500 m and there are several areas of
permanent habitation at over 4,000 m. These are in
three main regions of the world: the Andes of South
America, the highlands of Eastern Africa, and the
Himalayas of South-Central Asia. This review is
concerned with the effects of the altitude on visitors
and the ways by which the permanent high altitude
dwellers have adapted to their environment.
The two main challenges to life at high altitude
come from hypobaric hypoxia and the low ambient
temperatures. Temperature decreases about 1C for
each 150 m elevation, so that at 4,500 m temperature
is roughly 30C lower than at sea level. Barometric
pressure falls progressively with increasing altitude.
Up to about 2,500 m there are few if any effects of
hypoxia. Above 3,000 m some effects of hypoxia are
likely to be experienced and above 4,000 m adverse
effects would be experienced by most unacclimatized
visitors. However, many people live and work at
altitude with no apparent adverse effects. One such
example is Cerro de Pasco a busy mining town of
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j Abstract The effects of hypo-
baric hypoxia in visitors depend
not only on the actual elevation
but also on the rate of ascent.
Sympathetic activity increases and
there are increases in blood pres-
sure and heart rate. Pulmonary
vasoconstriction leads to pulmo-
nary hypertension, particularly
during exercise. The sympathetic
excitation results from hypoxia,
partly through chemoreceptor re-
ﬂexes and partly through altered
baroreceptor function. High pul-
monary arterial pressures may
also cause reﬂex systemic vaso-
constriction. Most permanent high
altitude dwellers show excellent
adaptation although there are dif-
ferences between populations in
the extent of the ventilatory drive
and the erythropoiesis. Some alti-
tude dwellers, particularly Ande-
ans, may develop chronic
mountain sickness, the most
prominent characteristic of which
being excessive polycythaemia.
Excessive hypoxia due to periph-
eral chemoreceptor dysfunction
has been suggested as a cause. The
hyperviscous blood leads to pul-
monary hypertension, symptoms
of cerebral hypoperfusion, and
eventually right heart failure and
death.
j Key words altitude Æ
mountain sickness Æ
hypoxia Æ polycythemia Æ
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baroreceptors Æ autonomic ner-
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Lima, Peru72,000 population at 4,300 m in the Peruvian Andes,
where much high altitude research has been under-
taken. At this altitude barometric pressure is
450 mmHg and without hyperventilation alveolar
oxygen tension would be only 34 mmHg.
Autonomic control in visitors
Most adaptive changes occur in the ﬁrst days and
weeks following arrival at altitude, and this is the
period when acute mountain sickness with cerebral
and/or pulmonary oedema may occur. Recent studies
in animals and man have highlighted the role of the
autonomic nervous system in adaptation and in par-
ticular the importance of sympathetic activation fol-
lowing high altitude exposure.
j Cardiovascular effects
Acute hypobaric hypoxia results in an increase in
resting heart rate and blood pressure and this is seen
both during altitude exposure [5] and during simu-
lated exposure using a hypobaric chamber [68]. Vogel
et al. [68, 69] demonstrated that the rate of ascent
inﬂuenced the magnitude of the tachycardia. Gradual
increases in altitude over two weeks resulted in larger
heart rate changes compared with an abrupt ascent.
Later, as subjects acclimatise at altitudes up to about
4,500 m, much of the increase in heart rate is lost and
resting heart rates return towards their sea level val-
ues.
Acute hypoxia also causes an increase in cardiac
output both at rest and for given levels of exercise.
This was seen both when breathing hypoxic gas at sea
level [34, 68, 69] and on acute exposure to high alti-
tude [21]. As subjects acclimatise to the altitude car-
diac output decreases although the heart rate can
remain high with a low stroke volume. This may be
due to a loss of plasma volume [23, 54].
The effect of hypoxia on the pulmonary circulation
is rapid, resulting in an increase in pulmonary vas-
cular resistance and pulmonary hypertension [49].
The maximum response occurs within 5 min [65].
Breathing 11% oxygen for 30 min increases pulmo-
nary artery pressure from 16 to 25 mmHg [72]. The
effect of hypoxia on the pulmonary circulation is even
more pronounced during exercise, as demonstrated in
the Operation Everest II studies [24] where pulmo-
nary artery pressure increased during near-maximal
exercise at 8840 m to 54 mmHg.
The mechanism of pulmonary artery vasocon-
striction initially involves inhibition of O2 sensitive
K
+ channels leading to depolarization of pulmonary
artery smooth muscle cells and activation of voltage
gated Ca
2+ channels causing Ca
2+ inﬂux and vaso-
constriction [48]. This process is immediately re-
versed by breathing oxygen. However, lowlanders
exposed to high altitude for 2–3 weeks develop pul-
monary hypertension that is not completely reversed
by oxygen breathing [24] suggesting remodelling of
pulmonary arterioles. Remodelling involves prolifer-
ation of smooth muscle cells and thickening of the
artery wall [57].
j Sympathetic activity
Acute hypoxia is a potent activator of sympathetic
activity [39, 56]. Studies in several species, including
dogs, rats and rabbits, showed that hypoxia stimu-
lated the sympathoadrenal system. Acute hypoxia in
spontaneously breathing anaesthetized animals cau-
ses increases in sympathetic nerve activity, increased
release of catecholamines, increases in heart rate and
regional vasoconstriction [28, 60]. However the effects
of hypoxia on the human sympathetic nervous system
are more difﬁcult to determine and often indirect
methods of assessment have been employed.
One method of assessment of sympathetic activity
in humans is from blood or urine levels of catechol-
amines. However, catecholamine levels are the net
resultant of secretion, spill-over, reuptake and excre-
tion [59, 18] and results must be interpreted with
caution. Mazzeo et al. [40] measured arterial nor-
adrenaline and adrenaline concentrations in subjects
at sea level, then after 4 h then 21 days at altitude
(4,300 m). They reported an initial decrease in nor-
adrenaline but by day 21 it had increased to 52%
above sea level values. Arterial adrenaline values
doubled following acute altitude exposure then de-
clined to only 26% above sea-level by day 21. In a later
study, however, the same authors [41] measured 24 h
urinary noradrenaline and adrenaline excretion and
venous plasma catecholames in women at sea level
and during 12 days of exposure to 4,300 m and re-
ported increases in both urinary noradrenaline and
adrenaline excretion after only one day at altitude and
increases in plasma catecholamines on day 4 at alti-
tude. During the 12 day period noradrenaline con-
tinued to increase as assessed both from urinary
excretion and in the plasma samples. Adrenaline
values however fell back to those recorded at sea level.
Rostrup [59] reported initial decreases in both plasma
noradrenaline and adrenaline which subsequently
recovered. Results from simulated hypoxia are also
conﬂicting with an increase in urinary adrenaline but
no change in noradrenaline [29] or no change in ei-
ther [71]. These results illustrate the difﬁculty in
assessing autonomic activity from blood or urine
catecholamines, but they do suggest that in the early
14stages of exposure to altitude there is an increase
mainly in adrenaline, but that later it is noradrenaline
that predominates.
The changes in catecholamines are more consistent
during exposure to chronic hypoxia. Calbet [10]
measured systemic and skeletal muscle noradrenaline
and adrenaline spillover in lowlanders after exposure
to 5,260 m. After 9 weeks plasma noradrenaline and
adrenaline concentrations were approximately 4 and 2
fold higher than the sea level values. These values
were similar to those in patients with compensated
chronic heart failure [2].
The heart rate at maximal exercise is reduced at
altitude. In Operation Everest II maximal heart rates
decreased from 160 at sea level to 118 at 8,848 m [54].
Given the evidence for elevated catecholamines at
altitude, at least during chronic exposure, this sug-
gests a down regulation of the cardiac b -adrenergic
receptors. Studies in rats following prolonged expo-
sure to hypobaric hypoxia have shown a decreased b-
adrenergic receptor density [30, 67]. Short exposures
to hypoxia (1–15 days) did not affect b-adrenergic
receptor density. However by 21 days there was a 24%
reduction. Leon-Velarde et al [35] exposed rats to a
simulated altitude of 5,500 m for 21 days and also
found a 24% reduction in b-adrenergic receptor
density in both left and right ventricles. They also
reported an increase in a1-adrenergic receptor density
in the left ventricle, although Morel et al [48], who
exposed rats to 5,500 m for 15 days, found no change
in a1-adrenergic receptor density in either left or right
ventricle. Density of adenosine receptors has also
been shown to be decreased by 46% following 30 day
exposure to 5,500 m simulated altitude in the rat
while muscarinic receptor density increased by 49%
[31].
Changes in receptor density have also been esti-
mated indirectly in man by determining the rate of
isoprenaline infusion required to increase heart rate
by 25 beats/min. The required rate increased with
increasing exposure to altitude and this was attributed
to a down regulation of the b-adrenergic receptors
[56]. Platelet a2-adrenergic receptor density decreased
after 4 weeks exposure to 5,050 m [19]. Changes in
a2-adrenergic receptor density on platelets may indi-
cate a similar change in the central nervous system
[53]. In the central nervous system a2-adrenergic
receptors are known to play an important role in
cardiovascular regulation [22]. Stimulation of these
receptors in the ventrolateral medulla has been shown
to reduce sympathetic and increase parasympathetic
outﬂow [55]. If a change in the density of these
receptors occurred it may explain many of the effects
of altitude on the autonomic system.
The effect on the parasympathetic system has been
assessed in humans from the responses to muscarinic
blockade. Following short exposures to hypoxia the
changes in heart rate following muscarinic blockade
became smaller [11]. However, Boushel et al. [8] ex-
posed subjects to an altitude of 5,260 m for 9 weeks
and then studied the effects of muscarinic blockade
both at rest and during exercise, and suggested that
there was an enhanced parasympathetic activity and
that this was responsible for the reduction in heart
rate seen during chronic adaptation to altitude.
j Muscle sympathetic nerve activity
Several studies have examined the effects of acute
hypoxia on muscle sympathetic nerve activity and
reported increases in discharge [17, 27]. Chronic hy-
poxia also enhances sympathetic activity and Hanson
and Sander [27] reported that, following exposure to
an altitude of 5,260 m for 4 weeks, activity remained
elevated 3 days following descent.
j Heart rate variability
Cardiac autonomic nerve activity is often assessed
noninvasively from spontaneous changes in heart
rate. This is inﬂuenced by respiration [9] and this
complicates many studies of hypoxia due to the
concomitant respiratory stimulation. High frequency
R–R interval power is considered to be associated
with cardiac parasympathetic activity whereas the low
frequency components are associated with both
parasympathetic and sympathetic activity. The ratio
of low to high frequency power is said to be an index
of the ‘‘sympathovagal balance’’. Power in both high
and low frequency bands were found to decrease at
altitude although the ratio of low to high frequency
power increased [32, 16, 17]. The increase in the ratio
is believed to imply that the sympathetic activity is
dominant compared to parasympathetic. These ﬁnd-
ings imply that acute exposure to hypoxia causes
decreased parasympathetic and increased sympathetic
tone and during acclimatization there is a progressive
shift toward still higher sympathetic tone.
j Arterial baroreflex
Studies in humans of baroreﬂex control at altitude or
simulated altitude have yielded contradictory results.
Sagawa et al. [61], using the neck chamber method,
reported that acute exposure to simulated altitude of
4,300 m had no effect on carotid baroreﬂex set point
for heart rate control but there was a 50% reduction
in the gain of the reﬂex. Halliwill and Minson [25, 26],
on the other hand, using nitroprusside and phenyl-
ephrine, found that hypoxic breathing increased set
15point but did not change gain. Studies of ‘‘spontane-
ous’’ baroreﬂex gain have indicated that it decreases
at altitude or simulated altitude [5, 6, 7, 63]. Inter-
pretation of these ﬁndings is complicated by the dif-
ferences in baseline blood pressures and heart rate.
Recently, Cooper et al. [15] reported that although
acute hypoxia did not change baroreceptor control of
heart rate it did decrease the gain of the vascular
resistance response without changing ‘‘set point’’.
j Mechanisms for sympathetic activation at high
altitude
The increase in sympathetic activity at altitude is
caused by both the direct and indirect effects of hy-
poxia. The role of chemoreceptors is reviewed by
Marshall [39]. Hypoxia acts directly on vascular
smooth muscle in the systemic circulation causing
relaxation and therefore hypotension. This, in turn,
would lead to baroreceptor-mediated sympathetic
excitation. Alterations in baroreﬂex function: an in-
crease in ‘‘set point’’ and possibly a decrease in gain,
are likely to contribute. An additional mechanism for
exciting sympathetic activity may also arise through
stimulation of pulmonary arterial baroreceptors. Hy-
poxia induces pulmonary hypertension and we have
recently reported that, in the anaesthetized dog, in-
creases in pulmonary artery pressure increase sys-
temic vascular resistance [38, 46].
Autonomic function in high altitude residents
j Healthy highlanders
Healthy high altitude dwellers show excellent adap-
tation to their environment. These adaptations are
likely to be associated with altered gene expression as
the expression of genes associated with vascular
control and reactions to hypoxia have been found to
be high in altitude dwellers [1]. Different communi-
ties, however, seem to adopt different adaptation
strategies [4]. For example Andeans hyperventilate to
decrease end-tidal and arterial CO2 levels to as low as
25 mmHg and have haemoglobin levels well above
those at sea-level. Ethiopian highlanders, on the other
hand, have CO2 and haemoglobins levels similar to
sea-level dwellers [13, 33].
Despite the successful adaptation of permanent
residents, some differences do occur. The carotid
body shows age-related hyperplasia but blunted re-
sponses to hypoxia [62]. High altitude dwellers have
been reported to show earlier cardiovascular degen-
erative changes with aging. Arterial wall stiffness is
greater and blood pressures are higher [51, 52]. High
altitude residents, both healthy subjects and patients
with chronic mountain sickness (see below) have
higher catecholamine levels when measured at alti-
tude than following descent to sea level [20]. Baro-
receptors, however, appear to function normally at
altitude [5]. We [45] examined cardiac and vascular
responses to neck chamber pressures and found that
responses were unaffected by descent to sea-level.
Moore et al. [47] also studied baroreceptor function
in anaesthetized dogs, which allows better control of
relevant variables. There was no difference in the gain
of the baroreﬂex control of vascular resistance be-
tween lowland animals and animals reared at altitude
(4,330 m). Set point, however, was lower in high
altitude animals which seems surprising in view of the
known hypertensive effect of hypoxia.
Blood volumes are larger in high altitude dwellers.
In Andeans this is due to a large packed cell volume
whereas in Ethiopians plasma volume was large [12,
13]. Probably as the result of the large blood volumes,
tolerance to orthostatic stress was greater than that in
sea-level residents [12, 14].
j Patients with chronic mountain sickness
Chronic mountain sickness (CMS, Monge’s disease;
[43]) is a condition frequently found in long-term
residents of high altitudes particularly in the Andes
where it is a major public health problem. It also
occurs in residents on the Tibetan plateau, although
not in Ethiopians [13].
Patients with CMS develop excessive polycythemia
and various clinical features including dyspnoea,
palpitations, insomnia, dizziness, headache, confu-
sion, loss of appetite, lack of mental concentration
and memory alterations. Patients may also complain
of decreased exercise tolerance, bone pain, acral
paraesthesia and occasionally haemoptysis. The
impairment of mental function may be reversed by
phlebotomy [42]. Physical examination reveals cya-
nosis, due to the combination of polycythemia and
low oxygen saturation, and a marked pigmentation of
the skin exposed to the sun. Hyperaemia of con-
junctivae is characteristic and the retinal vessels are
also dilated and engorged. The second cardiac sound
is frequently accentuated and there is an increased
cardiac size, mainly due to right ventricular hyper-
trophy. As the condition progresses, overt congestive
heart failure becomes evident, characterized by
dyspnoea at rest and during mild effort, peripheral
oedema, distension of superﬁcial veins, and progres-
sive cardiac dilation. A clinical score was devised in
the attempt to assess the severity of the syndrome and
to compare CMS cases within and between different
countries in the world [37].
16CMS is most likely the result of several inﬂuences
acting on subjects living at high altitudes. Hypoven-
tilation associated with aging has been proposed as
one of the main underlying mechanisms [64]. Many of
the clinical features may be attributed to the excessive
polycythemia which leads to hyperviscosity of the
blood and consequently impaired blood ﬂow and
impaired oxygen delivery to several organs including
the brain [44].
Sime et al. [64] reported a blunted ventilatory re-
sponse to hypoxia (VRH) in subjects with CMS and
suggested this as the basic underlying cause. How-
ever, the same effect may also occur in some subjects
without CMS [3, 62]. The function of the peripheral
chemoreceptors has been shown to be abnormal [36].
Studies have been carried out to examine the
plasticity of chemoreﬂexes to both long and short
term changes in blood gas tensions of chronically
hypoxic high-altitude natives with blunted respiratory
responses to hypoxia. It was found that natives who
had migrated to live at sea level had ventilatory re-
sponses to acute hypoxia (few minutes) which had
become similar to those of sea-level controls [21].
However, responses to sustained hypoxia (20 min)
remained markedly blunted. These results may ex-
plain the apparent discrepancy in previous studies.
Recent studies have examined cardiovascular and
cerebrovascular control in subjects with CMS. Ber-
nardi et al. [6] assessed baroreﬂex function and the
chemo- and baroreﬂex interactions in Andean sub-
jects with and without CMS. They found that subjects
with CMS showed a reduction in the responses to
stimulation of peripheral chemoreﬂexes. In addition,
these subjects also showed a reduction in the baro-
reﬂex control of heart rate and blood pressure. The
reduction in the arterial baroreﬂex correlated with an
increase in CMS score, and with an increase of hae-
moglobin levels. They interpreted these ﬁndings as
suggestive of a functional, reversible central depres-
sion rather than of the presence of an organic dys-
autonomia in CMS. They further suggested that the
observed baroreﬂex alteration might be involved in
the causation of some of the symptoms of CMS. In
another study on subjects with CMS, performed at
high altitude, the same authors showed that increas-
ing oxygen saturation for an hour by a slow breathing
pattern or by oxygen administration was associated
with increased arterial baroreﬂex sensitivity [33].
The major mechanism for the control of blood
pressure is through regulation of peripheral vascular
resistance, but most studies have examined only the
control of heart rate. We have recently studied the
responses of forearm vascular resistance to carotid
baroreceptor stimulation in high altitude residents
with and without CMS, both at their resident altitude
and shortly after descent to sea level. Results showed
that baroreﬂex ‘‘set point’’ was higher in CMS, but
only at altitude. At sea level, values were similar [45].
Cerebrovascular control Cerebral blood ﬂow is
known to be less in CMS patients than in healthy
controls and this is attributed to the high viscosity of
the blood. Villafuerte et al. [66] estimated that the
ideal haemoglobin level for maximal oxygen delivery
is 14.7 g/dl, a value similar to that of sea-level
dwellers. The cerebral circulation normally shows an
efﬁcient autoregulation whereby changes in cerebral
perfusion pressure have minimal effect on ﬂow.
Claydon et al. [14] assessed autoregulation from the
correlation between ﬂow and pressure during ortho-
static stress, where a signiﬁcant correlation with a
high coefﬁcient indicates poor autoregulation. Results
of this study showed that cerebrovascular autoregu-
lation was impaired in CMS patients. These ﬁndings
are compatible with those of Roach et al. [58] who
reported reduced cerebrovascular sensitivity to car-
bon dioxide in the presence of hypobaric hypoxia in
subjects with CMS.
Norcliffe et al. [50] determined the cerebrovascular
responses to hypoxia and hypercapnia, separately and
together, in CMS patients and normal high altitude
dwellers. CMS patients did not respond differently
from the normals, but in both groups at altitude the
sensitivity of the cerebral circulation to hypoxia was
less than that in sea level residents. Shortly after
descent to sea level, however, sensitivity increased.
Sensitivity to hypercapnia during hypoxia decreased
after descent.
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